|
2025
|
P/S
|
pharmaceutical preparations for the treatment of immune system related diseases and disorders; ph... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of immune system related diseases and disorders; ph... |
|
|
P/S
|
Providing medical information; Providing medical information in the field of pain treatments |
|
|
P/S
|
Providing health information to patients and caregivers; providing health care information; provi... |
|
|
P/S
|
Pharmaceuticals and medical treatments in the field of diabetes; cell therapy for medical or vete... |
|
|
P/S
|
Providing medical information, namely, consumer product information regarding medical products to... |
|
|
P/S
|
Pharmaceuticals and medicines for the treatment of cystic fibrosis, pain, sickle cell disease, be... |
|
|
P/S
|
Pharmaceuticals and medicines for the treatment of cystic
fibrosis, pain, sickle cell disease, b... |
|
|
Invention
|
Implantation devices, system, and methods.
Provided herein are devices, systems, and methods for... |
|
|
Invention
|
Anti-cd74 antibodies, conjugates and uses thereof. The disclosure provides anti-CD74 antibodies, ... |
|
|
Invention
|
Novel islet potency assay. Disclosed herein are compositions and methods related to differentiati... |
|
|
Invention
|
Differentiation of pancreatic islet cells. Disclosed herein are compositions and methods related ... |
|
|
Invention
|
Modified urokinase-type plasminogen activator polypeptides and methods of use.
Provided are modi... |
|
|
Invention
|
Genetically engineered cells. Disclosed herein are compositions and methods related to geneticall... |
|
|
Invention
|
Materials and methods for treatment of hemoglobinopathies.
Materials and methods for treating a ... |
|
|
Invention
|
Mucin-5b (muc5b) targeted sirna and antisense oligonucleotides and methods of use thereof.
Discl... |
|
|
Invention
|
Mucin-5b (muc5b) targeted sirna and antisense oligonucleotides and methods of use thereof. Disclo... |
|
|
Invention
|
Pharmaceutical compositions of alpha-1 antitrypsin modulators. SSS)-4-(8-fluoro-5-(4-fluoro-3-met... |
|
|
Invention
|
Enhanced differentiation of pancreatic islet cells.
Disclosed herein are compositions and method... |
|
|
Invention
|
Excision of exon 53 for treatment of duchenne muscular dystrophy. Compositions and methods for tr... |
|
|
Invention
|
N-(hydroxyalkyl (hetero)aryl) tetrahydrofuran carboxamides as modulators of sodium channels.
Com... |
|
|
Invention
|
Compositions for the treatment of cftr-mediated diseases. SRNNtert366)phenyl)-4-oxo-1,4-dihydroqu... |
|
|
Invention
|
Compositions for the treatment of cftr-mediated diseases.
The present invention relates to pharm... |
|
|
Invention
|
Combination of vanzacaftor, tezacaftor, deutivacaftor for use in treating cystic fibrosis. This a... |
|
|
Invention
|
Tandem guide rnas (tg-rnas) and their use in genome editing.
Compositions comprising tandem gRNA... |
|
2024
|
Invention
|
Stem cell derived islet differentiation.
Provided herein are methods of producing β cells and pr... |
|
|
Invention
|
Pharmaceutical composition and administrations thereof.
The present invention relates to pharmac... |
|
|
Invention
|
Promoters and trna constructs. Nucleic acids and compositions for improved gene editing are descr... |
|
|
Invention
|
Methods of enhancing stem cell differentiation into beta cells.
Disclosed herein are composition... |
|
|
Invention
|
Dosing regimens for treating pain.
Disclosed herein are methods of treating pain, comprising adm... |
|
|
Invention
|
Dosing regimens and formulations of suzetrigine for use in the treatment of acute and chronic pai... |
|
|
Invention
|
Methods of treatment for cystic fibrosis.
This application describes methods of treating cystic ... |
|
|
Invention
|
Substituted tetrahydrofurans as modulators of sodium channels.
Compounds, and pharmaceutically a... |
|
|
Invention
|
Membrane seals and projections for macroencapsulation devices.
A macroencapsulation device inclu... |
|
|
Invention
|
Membrane seals and projections for macroencapsulation devices. A macroencapsulation device includ... |
|
|
Invention
|
Devices and methods for delivering therapeutics.
The present invention provides devices and meth... |
|
|
Invention
|
Compounds useful as inhibitors of atr kinase.
The present invention relates to compounds useful ... |
|
|
Invention
|
Polynucleotides encoding cystic fibrosis transmembrane conductance regulator for the treatment of... |
|
|
Invention
|
Antiproliferation compounds and uses thereof.
The present invention provides compounds of Formul... |
|
|
Invention
|
Complement factor i dosing regimens for treating ocular diseases.
Provided herein are dosing reg... |
|
|
Invention
|
Materials and methods for treatment of hemoglobinopathies.
The present application provides mate... |
|
|
Invention
|
Modulators of cystic fibrosis transmembrane conductance regulator.
The present invention feature... |
|
|
Invention
|
Materials and methods for treatment of human genetic diseases including hemoglobinopathies.
The ... |
|
2023
|
Invention
|
Solid forms of a macrocyclic compounds as cftr modulators and their preparation.
Processes and m... |
|
|
Invention
|
Methods of treatment for cystic fibrosis.
This disclosure provides methods of treating cystic fi... |
|
|
Invention
|
Modulators of cystic fibrosis transmembrane conductance regulator.
This disclosure provides modu... |
|
|
Invention
|
Spiro piperidine derivatives as inhibitors of apol1 and methods of using same.
The disclosure pr... |
|
|
Invention
|
2-methyl-4',5'-dihydrospiro[piperidine-4,7'-thieno[2,3-c]pyran] derivatives as inhibitors of apol... |
|
|
Invention
|
2-methyl-4-phenylpiperidin-4-ol derivatives as inhibitors of apol1 and methods of using same.
Th... |
|
|
Invention
|
Methods of preparing and crystalline forms of (6a,12a)-17-amino-12-methyl-6,15-bis(trifluoromethy... |
|
2022
|
Invention
|
Indole derivatives as cftr modulators. Compounds of the present invention and pharmaceutically ac... |
|
|
Invention
|
Process for the synthesis of substituted tetrahydrofuran modulators of sodium channels.
Provided... |
|
|
Invention
|
Substituted tetrahydrofuran analogs as modulators of sodium channels.
Compounds of formula I, an... |
|
|
Invention
|
Engineered cpn1 constructs and variants.
Provided herein are carboxypeptidase N catalytic subuni... |
